Table 2.

Physical properties of the formulations and the efficiency of drug encapsulation.

Formulation (BP%)	Z-Average (nm)	PDI	%EE (±SD)
LipoD (0%)	211.2 ± 0.60	0.08 ± 0.03	0
CDD3 (18%)	253.0 ± 6.05	0.33 ± 0.01	58.2 ± 2.3
CDD2 (22%)	331.4 ± 4.74	0.47 ± 0.06	89.9 ± 1.0
CDD1 (25%)	360.9 ± 23.06	0.53 ± 0.07	98.4 ± 3.7

Abbreviation: PDI: polydispersity index; BP%: initiative weight percentage of BP; %EE: encapsulation efficiency (%); LipoD: comprising DMPC and cholesterol; CDD: BP represents the (2-hydroxypropyl)-β-cyclodextrin (CD)/LipoD formulation.